Literature DB >> 24983652

Are IMRT treatments in the head and neck region increasing the risk of secondary cancers?

Oscar Ardenfors1, Dan Josefsson, Alexandru Dasu.   

Abstract

BACKGROUND: Intensity-modulated radiation therapy (IMRT) has been increasingly employed for treating head and neck (H&N) tumours due to its ability to produce isodoses suitable for the complex anatomy of the region. The aim of this study was to assess possible differences between IMRT and conformal radiation therapy (CRT) with regard to risk of radiation-induced secondary malignancies for H&N tumours.
MATERIAL AND METHODS: IMRT and CRT plans were made for 10 H&N adult patients and the resulting treatment planning data were used to calculate the risk of radiation-induced malignancies in four different tissues. Three risk models with biologically relevant parameters were used for calculations. The influence of scatter radiation and repeated imaging sessions has also been investigated.
RESULTS: The results showed that the total lifetime risks of developing radiation-induced secondary malignancies from the two treatment techniques, CRT and IMRT, were comparable and in the interval 0.9-2.5%. The risk contributions from the primary beam and scatter radiation were comparable, whereas the contribution from repeated diagnostic imaging was considerably smaller.
CONCLUSION: The results indicated that the redistribution of the dose characteristic to IMRT leads to a redistribution of the risks in individual tissues. However, the total levels of risk were similar between the two irradiation techniques considered.

Entities:  

Mesh:

Year:  2014        PMID: 24983652     DOI: 10.3109/0284186X.2014.925581

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

Review 1.  Intensity-modulated radiotherapy for head and neck surgeons.

Authors:  Stanley I Gutiontov; Edward J Shin; Benjamin Lok; Nancy Y Lee; Ruben Cabanillas
Journal:  Head Neck       Date:  2015-12-26       Impact factor: 3.147

2.  Radiation-induced secondary malignancies for nasopharyngeal carcinoma: a pilot study of patients treated via IMRT or VMAT.

Authors:  Hsiao-Fei Lee; Jen-Hong Lan; Pei-Ju Chao; Hui-Min Ting; Hui-Chun Chen; Hsuan-Chih Hsu; Tsair-Fwu Lee
Journal:  Cancer Manag Res       Date:  2018-01-18       Impact factor: 3.989

3.  Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma.

Authors:  Fen Xue; Xiaoshuang Niu; Chaosu Hu; Xiayun He
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

4.  Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation.

Authors:  Emel Haciislamoglu; Gorkem Gungor; Gokhan Aydin; Emine Canyilmaz; Ozan Cem Guler; Ahmet Yasar Zengin; Kamil Mehmet Yenice
Journal:  J Appl Clin Med Phys       Date:  2020-07-16       Impact factor: 2.102

5.  Second primary oral squamous cell carcinoma after radiotherapy: a retrospective cohort study.

Authors:  Hao Song; Ranran Yang; Kailiu Wu; Chao Lou; Meng Xiao; Wei Guo; Guoxin Ren
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.